Bonvehí, P., Boutriau, D., Casellas, J., Weynants, V., Feron, C., & Poolman, J. (2010). Three Doses of an Experimental Detoxified L3-Derived Lipooligosaccharide Meningococcal Vaccine Offer Good Safety but Low Immunogenicity in Healthy Young Adults. American Society for Microbiology (ASM).
Chicago Stili AlıntıBonvehí, Pablo, Dominique Boutriau, Javier Casellas, Vincent Weynants, Christiane Feron, ve Jan Poolman. Three Doses of an Experimental Detoxified L3-Derived Lipooligosaccharide Meningococcal Vaccine Offer Good Safety but Low Immunogenicity in Healthy Young Adults. American Society for Microbiology (ASM), 2010.
MLA AlıntıBonvehí, Pablo, et al. Three Doses of an Experimental Detoxified L3-Derived Lipooligosaccharide Meningococcal Vaccine Offer Good Safety but Low Immunogenicity in Healthy Young Adults. American Society for Microbiology (ASM), 2010.